Possible Role for Immunotherapy in Early-Stage Breast Cancer – Medscape
Medscape |
Possible Role for Immunotherapy in Early-Stage Breast Cancer
Medscape CHICAGO — Immune checkpoint blockade may have a role in the presurgery treatment of high-risk, early-stage breast cancers, according to results from a phase 2 trial presented here at the American Society of Clinical Oncology (ASCO) 2017 Annual … |
